Literature DB >> 355929

[Acute hepatic failure and renal damage. Experimental and clinical studies].

D Galmarini, L Tarenzi, G Cantaluppi, L R Fassati, A Mauri, G Zanandrea, M P Fabiani, M Doglia, F Radice, G Viale, E Trabucchi.   

Abstract

Renal damage in acute hepatic failure induced in the pig by means of an hepatic state, temporary or permanent devascularisation Amanita phalloides poisoning or orthotopic liver transplant proved of slight degree, particularly in animals treated with replacement therapy. In the cases of animals that died in acute hepatic coma, on the other hand, renal cortex ischaemia and marked medullary congestion were constant. Histologically, the damage consisted of slight tubular nephrosis; this was more apparent in the proximal tubules. Evaluation of renal damage in 38 patients with acute hepatic failure was more complicated owing to the variety of clinical conditions (level of coma, hypovolaemia, intensive care and hepatic assistance). Nevertheless, a clear relation was established between the degree of liver damage and blood creatinine and creatinine clearance values. All patients who died presented liver cell necrosis of over 75%, blood creatinine values of more than 2 mg/100 ml, and less than 50 ml/min clearance. Tubular nephrosis was the predominant lesion. It appeared that renal damage was primarily pre-renal. No signs of a true hepatorenal syndrome could be made out.

Entities:  

Mesh:

Year:  1978        PMID: 355929

Source DB:  PubMed          Journal:  Minerva Med        ISSN: 0026-4806            Impact factor:   4.806


  2 in total

1.  Paeoniflorin exerts a nephroprotective effect on concanavalin A-induced damage through inhibition of macrophage infiltration.

Authors:  Cheng Liu; Zhuoan Cheng; Yunman Wang; Xiuqin Dai; Jie Zhang; Dongying Xue
Journal:  Diagn Pathol       Date:  2015-07-25       Impact factor: 2.644

2.  Renoprotective Effects of Total Glucosides from Paeony against Nephrotoxicity Induced by Total Alkaloids from Semen Strychni.

Authors:  Mingming Lv; Meiyu Zhang; Yezhe Cheng; Kexia Zhang; Chenzhi Hou; Xiaohui Chen
Journal:  Evid Based Complement Alternat Med       Date:  2017-10-22       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.